Prostate-Specific Antigen testing in men between 40 and 70 years in Brazil: database from a check-up program

The European study ERSPC [The European Prostate Cancer Screening Trial] randomized a population of 162,243 men between 55 and 69 years old, for screening with PSA (n = 81,816)

In this regard, in an attempt to limit the uncertainty regarding the long-term risk of a prostate cancer that is found to be of low grade on a prostate biopsy, subclassification of

This was compared with the Scandinavian Prostate Cancer Group 4 (SPCG-4) trial of radical prostatectomy versus watchful waiting in men with prostate can- cer, which showed

EDITORIAL COMMENT: LACK OF EVIDENCE OF HPV ETIOLOGY OF PROSTATE CANCER FOLLOWING RADICAL SURGERY AND HIGHER FREQUENCY OF THE ARG/PRO GENOTYPE IN TURKISH MEN WITH PROSTATE CANCER..

Clinical performance of serum prostate- specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history

Prostate-specific antigen adjusted for the transition zone volume versus free- to-total prostate-specific antigen ratio in predicting prostate cancer.. Zisman A, Leibovici

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. Heidenreich A,

Observando a figura 11 verifica-se que as concentrações mais baixas de antifúngico não alteraram a concentração celular viável dos biofilmes das três estirpes, que